뉴욕의 여포성 림프종 임상 시험
여포성 림프종 관련 연구 30개가 뉴욕 내 여러 지역에서 참여자를 모집하고 있습니다.
뉴욕의 도시
- New York City연구 24개
- Queens연구 7개
- Greenburgh연구 6개
- Buffalo연구 5개
- Staten Island연구 4개
- New Rochelle연구 4개
- Rochester연구 4개
공식 연구 텍스트(영어)
A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)
- Icahn School of Medicine at Mount Sinai ( Site 1325), New York
피험자 모집 중2/3상
18세 이상 · 모든 성별 · 2026. 11. 13. 업데이트됨 · NCT07634471A Phase 2 Study of Epcoritamab in Patients With Follicular Lymphoma and Marginal Zone Lymphoma Not Accomplishing a Complete Response With Upfront Therapy
- Icahn School of Medicine at Mount Sinai, New York
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT06510361A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
- Icahn School of Medicine at Mt Sinai, New York
- Stony Brook University Hospital, Stony Brook
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT06091254A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma
- Stony Brook University Hospital, Stony Brook
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT06149286A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
- New York University (NYU) Clinical Cancer Center, New York
- Weill Cornell Medicine, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07101328A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
- Columbia University, New York
- University of Rochester, Rochester
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07226843Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
- Northwell Health Imbert Cancer Center, Bay Shore
- NYU Langone Hospital - Brooklyn, Brooklyn
- Memorial Sloan Kettering Commack, Commack
- 외 9개
피험자 모집 중3상
12세 이상 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT07215910rTMS and Cognitive-behavioral Therapy for Cocaine Use Disorder
- New York State Psychiatric Institute (NYSPI) / Substance Treatment and Research Service (STARS), New York
피험자 모집 중
22세 ~ 65세 · 모든 성별 · 2026. 11. 2. 업데이트됨 · NCT05974202A Study of Zedoresertib (Debio 0123) in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Zedoresertib (Debio 0123) in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
- New York University Langone Medical Center, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 28. 업데이트됨 · NCT05765812Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
- New York Medical College, Valhalla
피험자 모집 중1/2상
13세 ~ 90세 · 모든 성별 · 2026. 10. 26. 업데이트됨 · NCT06533579A Study of Reduced Dose Radiation Therapy for People With B-Cell Lymphomas
- Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- 외 1개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 10. 26. 업데이트됨 · NCT07029217Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL
- New York Medical College, Valhalla
피험자 모집 중2상
3세 ~ 31세 · 모든 성별 · 2026. 10. 23. 업데이트됨 · NCT02393157Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
- NYU Langone Hospital - Long Island, Mineola
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 10. 21. 업데이트됨 · NCT06860594A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
- Research Site, Albany
- Research Site, Brooklyn
- Research Site, Mineola
- 외 4개
피험자 모집 중3상
18세 ~ 130세 · 모든 성별 · 2026. 10. 21. 업데이트됨 · NCT06549595SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- NYU Langone Health, New York
- Icahn School of Medicine at Mount Sinai, New York
- Columbia University Medical Center, New York
- 외 2개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 10. 19. 업데이트됨 · NCT05303519Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
- Research Site, New York
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 10. 14. 업데이트됨 · NCT06526793A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies
- University of Rochester, Rochester
피험자 모집 중관찰 연구
0세 이상 · 모든 성별 · 2026. 10. 9. 업데이트됨 · NCT07154823A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
- Roswell Park Comprehensive Cancer Center, Buffalo
- Columbia University Medical Center, New York
- Weill Cornell Medical College Newyork Presbyterian Hospital, New York
- 외 1개
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 5. 업데이트됨 · NCT05006716A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
- Research Site, New York
- Research Site, New York
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT06542250Epco, Zanu, Ritux for R/R FL or MZL
- Memorial Sloan Kettering Cancer Center, New York
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06563596Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
- Mount Sinai Medical Center, New York
피험자 모집 중3상
12세 ~ 100세 · 모든 성별 · 2026. 9. 11. 업데이트됨 · NCT06784752Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
- Roswell Park Comprehensive Cancer Center, Buffalo
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
- Montefiore Medical Center, The Bronx
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT05826535A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma
- Memorial Sloan Kettering Suffolk- Commack (Limited protocol activities), Commack
- Memorial Sloan Kettering Westchester (Limited protocol activities), Harrison
- Memorial Sloan Kettering Cancer Center, New York
- 외 1개
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 8. 10. 업데이트됨 · NCT05389293This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma
- Roswell Park Cancer Institute, Buffalo
- Memorial Sloan Kettering Cancer Center - Bergen, New York
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 7. 24. 업데이트됨 · NCT07121946Chronic CED of TPT for Recurrent Malignant Glioma
- Columbia University Irving Medical Center / NewYork-Presbyterian Hospital, New York
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 6. 15. 업데이트됨 · NCT06666712Epcoritamab and Rituximab for First-line Follicular Lymphoma
- Icahn School of Medicine at Mount Sinai Hospital, New York
- University of Rochester Medical Center, Rochester
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 5. 22. 업데이트됨 · NCT05783609Autologous Stem Cell Transplant Followed by Polatuzumab Vedotin in Patients With B-cell Non-Hodgkin and Hodgkin Lymphoma
- New York Medical Center, Valhalla
피험자 모집 중1/2상
12세 ~ 70세 · 모든 성별 · 2026. 4. 15. 업데이트됨 · NCT04491370Study of SGR-1505 in Mature B-Cell Neoplasms
- Roswell Park Comprehensive Cancer Center, Buffalo
- Weill Cornell, New York
- Montefiore Medical Center, The Bronx
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 2. 13. 업데이트됨 · NCT05544019AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
- Optum Medical Care PC, Westbury
피험자 모집 중1상
18세 이상 · 모든 성별 · 2025. 12. 10. 업데이트됨 · NCT05602363SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Buffalo
- Massive Bio SYNERGY-AI site, Hempstead
- Massive Bio SYNERGY-AI site, Manhasset
- 외 2개
피험자 모집 중관찰 연구
전 연령 · 모든 성별 · 2025. 10. 28. 업데이트됨 · NCT03452774ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.